Browsing by Author Pan, C

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)Citation
2009Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trialAnderson, Craig; Chalmers, John; de Galan, Bastiaan; Hackett, Maree; MacMahon, Stephen; Neal, Bruce; Patel, Anushka; Pillai, Avineshwaran; Woodward, Mark; Zoungas, Sophia; Cooper, Mark; Dufouil, C; Grobbee, D; Hamet, Pavel; Heller, Simon; Lisheng, Liu; Mancia, Giuseppe; Pan, C; Poulter, N.; Travert, F; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; School of Public Health: NH&MRC Clinical Trials Centre; The George Institute for International Health; The George Institute for International HealthCognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial, Diabetologia: clinical and experimental diabetes and metabolism, vol.52, 11,pp 2328-2336
2011Does Glycemic Control Offer Similar Benefits Among Patients With Diabetes in Different Regions of the World?: Results from the ADVANCE trialChalmers, John; Neal, Bruce; Patel, Anushka; Woodward, Mark; Zoungas, Sophia; Heller, Simon; Januszewicz, Andrzej; Joshi, Prashant; Liu, Lisheng; Pan, C; Poulter, Neil; Tandon, Nikhil; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global HealthDoes Glycemic Control Offer Similar Benefits Among Patients With Diabetes in Different Regions of the World?: Results from the ADVANCE trial, Diabetes Care, vol.34, 12, 2011,pp 2491-2495
2009Effects of intensive blood glucose control on vascular outcomes in patients with type 2 diabetesBillot, Laurent; Bompoint, Severine; Chalmers, John; de Galan, Bastiaan; Joshi, Rohina; MacMahon, Stephen; Neal, Bruce; Patel, Anushka; Woodward, Mark; Cooper, Mark; Glasziou, Paul; Grobbee, Diederick E.; Hamet, Pavel; Harrap, Stephen B.; Heller, Simon; Liu, Lisheng; Mancia, Giuseppe; Marre, Michel; Mogensen, Carl-Erik; Pan, C; Poulter, Neil; Rodgers, Anthony; Travert, F; Williams, Bryan; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International HealthEffects of intensive blood glucose control on vascular outcomes in patients with type 2 diabetes, New England Journal of Medicine, vol.358,(24),2009,pp 2560-2572
2010The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: PreteraxChalmers, John; Colagiuri, Stephen; Kengne, Andre; Neal, Bruce; Patel, Anushka; Woodward, Mark; Grobbee, Diederick E.; Hamet, Pavel; Heller, Simon; Marre, Michel; Pan, C; Zoungas, Sophia; The George Institute for International Health; Central Clinical School: Medicine; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International HealthThe Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax, Diabetologia: clinical and experimental diabetes and metabolism, vol.53, 5,pp 821-831